Introduction to Oncology Conference

Join us for the Oncology Conference 2025, a global virtual event taking place on September 23-24, 2025, dedicated to advancing cancer research, treatment, and patient care. This online conference will unite leading oncologists, researchers, clinicians, and healthcare professionals to share groundbreaking discoveries, innovative therapies, and the latest advancements in oncology. Organized by Research Summit, the event focuses on the theme “Innovating Treatments Shaping the Future of Cancer Care” and will feature keynote speeches, expert panels, research presentations, and virtual exhibitions. Attendees can connect and collaborate from anywhere in the world, gaining valuable knowledge and networking opportunities. Be part of this transformative event to drive progress and improve outcomes in cancer care worldwide!

Key Areas of Oncology

• Cancer Diagnosis & Screening: Early detection through imaging, biomarkers, and genetic testing improves treatment outcomes and survival rates.
• Treatment & Therapeutic Advances: Innovations in chemotherapy, radiation therapy, immunotherapy, and precision medicine enhance patient care and recovery.
• Prevention & Risk Factors: Lifestyle changes, genetic counseling, and environmental awareness reduce cancer risks and support long-term health.

Market Insights in Oncology<

The global oncology market has witnessed significant growth over the past decade due to rising cancer prevalence, advances in treatment options, and increased research funding. Conferences focusing on oncology have expanded to address evolving areas such as immunotherapy, precision medicine, and AI applications. From 2018 to 2024, the number of oncology-related conferences, attendees, and industry participation have grown annually by an estimated 8-12%. Innovations in cancer therapies and diagnostics are driving interest and investments, while virtual and hybrid event formats have broadened global reach, contributing to steady market expansion. This growth reflects increased collaboration between academia, healthcare providers, and pharma, highlighting the oncology conference sector as a critical platform for knowledge exchange and innovation.

Target Audience

• Oncologists & Cancer Specialists: Experts diagnosing, treating, and managing various types of cancer.
• Radiologists & Imaging Experts: Professionals using advanced imaging techniques for cancer detection and monitoring.
• Surgeons & Surgical Oncologists: Specialists performing cancer-related surgeries for tumor removal and treatment.
• Pathologists & Laboratory Researchers: Scientists studying cancer cells and biomarkers for precise diagnosis.
• Pharmaceutical Scientists & Drug Developers: Innovators creating targeted therapies, immunotherapies, and chemotherapy drugs.
• Geneticists & Precision Medicine Experts: Specialists using genomics to personalize cancer treatments and risk assessment.
• Palliative Care & Pain Management Specialists: Professionals ensuring comfort and quality of life for cancer patients.
• Medical & Nursing Professionals: Care providers offering treatment, education, and patient support throughout therapy.
• Academic Researchers & Policy Makers: Scholars driving cancer research, awareness campaigns, and healthcare policies.

Key Topics & Tracks

Explore the latest advancements and research in Oncology through our comprehensive tracks:

Cancer Stem Cell Therapy

• Cancer stem cell therapy targets the root cells responsible for tumor growth and relapse, aiming to eradicate these resilient cells. By focusing on stem-like cancer cells, this treatment strategy seeks to improve long-term outcomes and prevent recurrence.

CAR T Cell Immunotherapy

• CAR T cell immunotherapy modifies a patient’s T cells to recognize and destroy cancer cells. This personalized approach has shown success in hematologic cancers, harnessing the immune system for highly targeted, effective treatment.

Precision Oncology

• Precision oncology customizes cancer treatment based on genetic and molecular profiling of tumors. By identifying specific mutations and biomarkers, therapies can be tailored for improved efficacy and reduced side effects.

Cancer Biopsy Methods

• Biopsy techniques are critical for cancer diagnosis and treatment planning. Advances include minimally invasive methods and liquid biopsies, enabling accurate tumor characterization with reduced patient discomfort.

Bioprinting Tumor Models

• 3D bioprinting creates complex, patient-specific tumor models for studying cancer behavior and drug response. These models enhance research by replicating tumor microenvironments more realistically than traditional cultures.

Nanotech Cancer Treatments

• Nanotechnology delivers drugs at the nanoscale, improving targeting and reducing systemic toxicity. Nanocarriers enable controlled release and enhanced penetration, revolutionizing cancer treatment delivery.

Robotic & Surgical Oncology

• Robotic-assisted surgery offers precision and minimally invasive options in cancer treatment. These technologies reduce recovery times and improve surgical outcomes, particularly in complex oncologic procedures.

Chemotherapy & Drug Therapy

• Chemotherapy remains a cornerstone in cancer treatment, using cytotoxic drugs to kill rapidly dividing cells. Advances in pharmacology have improved drug specificity and reduced side effects.

Cancer Biomarkers

• Biomarkers are measurable indicators of cancer presence or progression. They assist in early detection, prognosis, and treatment monitoring, supporting personalized therapy strategies.

Tumor Microenvironment

• The tumor microenvironment includes non-cancerous cells and structures surrounding tumors, influencing growth and response to therapy. Targeting this environment is a growing area in cancer treatment research.

Cancer Biology & Pathophysiology

• Understanding the cellular and molecular mechanisms driving cancer development and progression is fundamental for developing effective therapies and improving patient outcomes.

Induced Pluripotent Stem Cells

• Induced pluripotent stem cells (iPSCs) can differentiate into various cell types and are used for cancer modelling and regenerative therapies, providing insights into tumor biology.

Patient-Derived Organoids

• Patient-derived organoids are 3D cultures grown from tumor cells that closely mimic patient tumors, facilitating personalized drug testing and therapy optimization.

Cancer Treatment Resistance

• Treatment resistance occurs when cancer cells adapt to evade therapies, leading to relapse. Understanding mechanisms behind resistance is crucial to developing more durable treatments.

Pricing

Exclusive Offers	Early Bird Deadline Valid till 30-Jun-25	Standard Offer Valid from 01-Jul-25 till 20-Aug-25	Last Call Price Valid from 21-Aug-25 till 22-Sep-25
Speaker / Presenter Benefits	£199	£299	£399
Listener / Delegate Benefits	£199	£299	£399
Student Benefits	£99	£199	£299
Poster Benefits	£99	£199	£299
Register Now (Early Bird) Register Now (Standard) Register Now (Last Call)

Key Benefits of Membership

Join our exclusive conference and unlock a comprehensive package of professional development opportunities designed to advance your career and research.